High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study. (Q52608444)
Jump to navigation
Jump to search
scientific article published in January 1987
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study. |
scientific article published in January 1987 |
Statements
High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study. (English)
H D Preisler
A Raza
M Barcos
N Azarnia
R Larson
I Walker
M Browman
H Grunwald
P D'Arrigo
T Doeblin
1 January 1987
5
1
75-82